infecti
diseas
hiv
hepat
b
infect
pose
omnipres
threat
global
health
reliabl
fast
accur
sensit
platform
deploy
pointofcar
poc
multipl
set
airport
offic
detect
infecti
pathogen
essenti
manag
epidem
possibl
biolog
attack
best
knowledg
viral
load
technolog
adapt
poc
set
exist
today
due
critic
technic
biolog
challeng
present
first
time
broadli
applic
technolog
quantit
nanoplasmonicbas
intact
viru
detect
clinic
relev
concentr
sens
platform
base
uniqu
nanoplasmon
properti
nanoparticl
util
immobil
antibodi
select
captur
rapidli
evolv
viral
subtyp
demonstr
captur
detect
quantif
multipl
hiv
subtyp
b
c
e
g
subtyp
panel
high
repeat
sensit
specif
copiesml
ie
subtyp
use
spike
whole
blood
sampl
clinic
discard
hivinfect
patient
whole
blood
sampl
valid
gold
standard
ie
rtqpcr
platform
technolog
offer
assay
time
hour
minut
hour
captur
minut
detect
data
analysi
present
platform
also
abl
captur
intact
virus
high
effici
use
immunosurfac
chemistri
approach
directli
whole
blood
sampl
without
sampl
preprocess
step
spindown
sort
evid
present
show
system
accur
repeat
reliabl
addit
present
platform
technolog
broadli
adapt
detect
pathogen
reason
welldescrib
biomark
adapt
surfac
chemistri
thu
broadli
applic
detect
platform
hold
great
promis
implement
potenti
poc
set
hospit
primari
care
set
detect
infecti
agent
eg
viru
bacteria
critic
homeland
secur
public
militari
health
recent
year
infecti
diseas
especi
viral
outbreak
hiv
tremend
global
healthcar
impact
sinc
virus
could
rapidli
evolv
spread
turn
pandem
instanc
hivaid
devast
global
impact
caus
million
death
identif
control
forthcom
epidem
possibl
develop
reliabl
accur
sensit
diagnost
technolog
abil
tailor
multipl
set
detect
virus
still
pose
signific
biolog
engin
challeng
biolog
challeng
aris
due
presenc
multipl
subtyp
virus
make
difficult
achiev
repeat
reliabl
captur
effici
clinic
specimen
without
demand
lengthi
sampl
prepar
step
instanc
monitor
viral
load
hiv
pointofcar
poc
still
unaddress
challeng
tradit
detect
techniqu
cultur
enzymelink
immunosorb
assay
elisa
polymeras
chain
reaction
pcr
implement
poc
set
without
wellequip
laboratori
cell
cultur
timeconsum
costli
technic
demand
method
requir
skill
technician
ad
problem
virus
cultur
elisabas
method
multipl
sampl
step
reagent
requir
although
pcr
technolog
offer
versatil
power
detect
platform
clinic
sampl
common
viral
subtyp
requir
parallel
test
extern
standard
complex
multistep
manipul
laborintens
sampl
prepar
plasma
separ
rna
extract
amplif
expens
reagent
detect
thu
simpl
specif
accur
reliabl
viral
load
assay
necessari
avoid
viral
propag
initi
treatment
labelfre
biodetect
platform
electr
mechan
optic
mechan
recent
use
detect
infecti
agent
biosens
technolog
offer
multipl
pathogen
diseas
detect
applic
rang
laboratori
research
medic
diagnost
includ
drug
developmenttreat
engag
biolog
threat
militari
applic
platform
elimin
requir
fluoresc
radioact
label
andor
enzymat
detect
enabl
easytous
inexpens
poc
test
addit
silicon
nanowir
nanotub
use
detect
biolog
materi
virus
human
sampl
fact
optic
biosens
platform
hold
great
promis
monitor
biomolecular
bind
signal
detect
relev
biolog
interact
small
sampl
volum
without
physic
connect
light
sourc
biosens
area
aspect
offer
advantag
sensit
detect
limit
metal
nanoparticl
recent
use
drug
deliveri
clinic
diagnost
nanoplasmon
properti
present
advantag
monitor
chang
light
coupl
sens
surfac
associ
andor
dissoci
bioagentsmolecul
onto
metal
nanoparticl
lead
chang
wavelength
modif
metal
nanoparticl
surfac
caus
peak
shift
maximum
extinct
wavelength
enabl
broad
window
spectral
measur
high
signaltonois
ratio
thu
biosens
approach
use
variou
biochem
sens
platform
spectroscopi
allow
picomolar
sensit
detect
protein
nucleic
acid
interact
howev
number
engin
sampl
challeng
product
clinic
test
metal
nanoparticlebas
detect
method
first
typic
chemic
physic
modif
nanoparticl
eg
plasma
treatment
exposur
highli
acid
condit
lead
irrevers
aggreg
result
degrad
optic
characterist
also
exist
nanoparticlebas
pathogen
detect
method
suffer
challeng
associ
direct
exposur
unprocess
whole
blood
includ
nonspecif
bind
requir
extens
sampl
prepar
thu
reduc
clinic
relev
poc
applic
current
diagnost
test
eg
pcr
elisa
requir
sampl
preprocess
includ
plasma
separ
prevent
inaccuraci
signal
amplif
quantif
step
also
signific
challeng
develop
biosens
platform
detect
multipl
subtypespathogen
clinic
patient
sampl
although
plasmon
reson
principl
util
other
protein
nucleic
acid
detect
applic
intact
viral
detect
viral
load
quantif
perform
unprocess
whole
blood
demonstr
first
time
reliabl
labelfre
fluorescencefre
repeat
hiv
viral
load
quantif
platform
use
nanoplasmon
optic
detect
system
multipl
viral
subtyp
hivinfect
patient
sampl
unprocess
whole
blood
hiv
captur
biosens
surfac
figur
modifi
layerbylay
antibodi
immobil
figur
evalu
gold
nanoparticl
bind
seed
polystyren
surfac
rang
polyllysin
pll
concentr
mgml
evalu
linear
concentrationdepend
wavelength
shift
observ
figur
individu
wavelength
peak
bare
gold
nanoparticl
observ
nm
pll
concentr
increas
mgml
wavelength
peak
observ
nm
due
increas
number
aminetermin
group
polym
figur
use
curv
fit
method
describ
materi
method
section
spectral
measur
data
analysi
section
wavelength
correspond
extinct
peak
calcul
wavelength
spectrum
experi
mgml
pll
concentr
chosen
avoid
excess
dilut
step
reduc
possibl
variat
surfac
chemistri
concentr
result
high
extinct
coeffici
due
highest
gold
nanoparticl
bind
onto
pll
treat
surfac
figur
correspond
wavelength
data
pll
concentr
incub
time
present
tabl
follow
modif
step
surfac
rins
pb
three
time
minim
variat
wavelength
intens
measur
metal
nanoparticl
vari
size
shape
materi
present
differ
maximum
wavelength
point
properti
allow
tune
nanoplasmon
wavelength
point
throughout
visibl
nearinfrar
infrar
region
electromagnet
spectrum
offer
flexibl
avoid
batchtobatch
variat
creat
reproduc
platform
use
singl
batch
gold
nanoparticl
solut
studi
evalu
surfac
chemistri
control
group
unmodifi
nm
diamet
gold
nanoparticl
util
individu
wavelength
peak
gold
nanoparticl
reproduc
observ
nm
p
figur
correspond
peak
shift
pll
modif
measur
nm
repres
statist
signific
p
differ
goldcoat
surfac
figur
follow
gold
nanoparticl
coat
pll
modifi
surfac
acid
mua
selfassembl
monolay
onto
gold
nanoparticl
layer
gener
carboxyl
group
surfac
gold
nanoparticl
layer
antibodi
immobil
favor
orient
use
neutravidin
higher
captur
effici
toward
bioagent
immobil
physic
absorpt
chemic
bind
antibodi
onto
surfac
immobil
biotinyl
antibodi
hiv
captur
surfac
modifi
neutravidin
end
neutravidin
modif
statist
signific
wavelength
peak
shift
observ
nm
respect
mua
step
p
figur
prevent
nonspecif
bind
bovin
serum
albumin
bsa
solut
use
block
agent
block
agent
result
statist
signific
peak
shift
p
figur
biotinyl
polyclon
antibodi
incub
neutravidin
coat
surfac
observ
biotinyl
antibodi
result
statist
signific
wavelength
peak
shift
compar
bsa
step
nm
p
figur
evalu
repeat
surfac
chemistri
defin
follow
relat
ws
wavelength
shift
sem
standard
error
mean
literatur
repeat
defin
close
agreement
result
measur
experi
carri
condit
repeat
paramet
describ
percent
variat
wavelength
shift
measur
surfac
modif
paramet
evalu
wavelength
extinct
intens
measur
surfac
modif
figur
overal
repeat
paramet
observ
wavelength
extinct
intens
measur
respect
figur
result
indic
surfac
chemistri
repeat
enabl
feasibl
nanoplasmon
platform
figur
evalu
potenti
drift
background
signal
nois
due
potenti
chemicalphys
chang
nonspecif
bind
surfac
assess
system
use
whole
blood
hiv
spike
whole
blood
clinic
hivinfect
patient
sampl
control
measur
biosens
surfac
function
polyclon
antibodi
use
addit
unprocess
whole
blood
without
virus
result
statist
signific
peak
shift
nm
p
figur
statist
analysi
result
pvalu
obtain
use
nonparametr
kruskalw
oneway
analysi
varianc
follow
mannwhitney
u
test
bonferroni
correct
also
present
tabl
blood
sampl
spike
copiesml
copiesml
copiesml
copiesml
copiesml
copiesml
copiesml
subtyp
b
c
e
g
panel
respect
sampl
result
statist
signific
wavelength
shift
nm
nm
nm
nm
nm
nm
nm
subtyp
b
c
e
g
panel
respect
p
figur
thu
observ
polyclon
antibodi
reproduc
repeat
captur
multipl
viru
subtyp
b
c
e
g
panel
use
platform
figur
statist
analysi
result
pvalu
obtain
use
nonparametr
kruskalw
oneway
analysi
varianc
follow
mannwhitney
u
test
bonferroni
correct
also
present
tabl
evalu
limit
detect
compar
wavelength
shift
valu
control
whole
blood
without
hiv
low
hiv
concentr
differ
subtyp
limit
detect
observ
copiesml
hiv
subtyp
copiesml
hiv
subtyp
b
copiesml
hiv
subtyp
c
copiesml
hiv
subtyp
copiesml
hiv
subtyp
e
copiesml
hiv
subtyp
g
copiesml
hiv
subtyp
panel
thu
captur
variou
subtyp
use
polyclon
antibodi
present
differ
limitofdetect
valu
figur
limit
detect
could
improv
collect
data
larger
activ
captur
detect
area
increas
sampl
volum
present
origin
experiment
data
correspond
curv
fit
figur
ag
introduc
hiv
nanoplasmon
platform
repres
observ
wavelength
extinct
intens
shift
present
figur
h
character
polystyren
surfac
use
atom
forc
microscopi
afm
surfac
modif
step
unmodifi
polystyren
surfac
observ
rough
nm
express
root
mean
squar
rm
measur
standard
error
mean
sem
figur
modif
surfac
mgml
pll
rm
rough
observ
nm
figur
gold
nanoparticl
immobil
pll
modifi
surfac
gave
rm
rough
nm
figur
observ
statist
signific
differ
unmodifi
pllmodifi
polystyren
surfac
p
figur
also
observ
signific
differ
gold
nanoparticl
immobil
unmodifi
polystyren
surfac
p
figur
henc
gold
nanoparticl
immobil
surfac
led
significantli
greater
chang
rm
rough
compar
pll
modifi
surfac
p
statist
analysi
result
pvalu
obtain
use
nonparametr
kruskalw
oneway
analysi
varianc
follow
mannwhitney
u
test
bonferroni
correct
present
tabl
quantit
evalu
coat
uniform
densiti
gold
nanoparticl
afm
analysi
perform
differ
area
modifi
surfac
assess
coat
uniform
gold
nanoparticl
follow
previous
report
method
use
public
domain
nih
imagej
softwar
http
rsbinfonihgovnihimag
imag
first
convert
imag
use
public
domain
nih
imagej
softwar
version
threshold
adjust
au
au
estim
gold
nanoparticl
coat
uniform
calcul
util
threshold
rang
immobil
gold
nanoparticl
present
uniform
coat
biosens
surfac
thu
uniform
dens
coat
nanoplasmon
platform
produc
modifi
surfac
incub
prevent
evapor
thu
observ
coffe
ring
effect
gold
nanoparticl
incub
surfac
chemistri
addit
show
hiv
particl
captur
surfac
use
sem
imag
figur
sem
imag
multipl
locat
chip
show
aggreg
captur
virus
coat
uniform
densiti
gold
nanoparticl
pll
modifi
surfac
also
qualit
evalu
use
sem
figur
sem
experi
qualit
demonstr
gold
nanoparticl
uniformli
distribut
surfac
observ
afm
analysi
evalu
number
gold
nanoparticl
activ
area
interact
viru
particl
defin
follow
equat
n
number
gold
nanoparticl
activ
area
v
volum
viru
solut
ml
c
number
copi
virus
per
ml
b
optic
beam
area
mm
whole
surfac
area
p
captur
effici
virus
r
r
surfac
area
ratio
viru
gold
nanoparticl
earlier
result
demonstr
captur
effici
hiv
spike
whole
blood
sampl
use
polyclon
antibodi
glass
surfac
base
result
assum
captur
effici
virus
multiwel
plate
support
inform
theoret
model
captur
effici
section
plot
number
gold
nanoparticl
roughli
estim
contact
virus
activ
area
figur
nanoplasmon
platform
use
detect
sever
protein
nucleic
acid
interact
picomolar
sensit
literatur
less
pm
streptavidin
molecul
molecular
weight
kda
result
nm
wavelength
shift
limit
detect
system
also
present
streptavidin
moleculesnanoparticl
nm
diamet
captur
intact
virus
use
receptor
protein
molecular
weight
kda
locat
hiv
surfac
addit
nanoplasmon
extinct
spectra
nanoparticl
affect
neighbor
nanoparticl
properti
use
measur
length
flexibl
singlestrand
dna
strand
posit
nanoparticl
pair
shown
short
interparticl
distanc
amplifi
local
electromagnet
field
caus
increas
local
surfac
plasmon
signal
enhanc
field
hotspot
recent
use
nanoplasmon
detect
adenoviru
particl
exact
natur
enhanc
report
function
nanoparticl
arrang
surfac
effect
refract
index
distribut
nanoparticl
evalu
limit
detect
broad
applic
nanoplasmon
detect
platform
biolog
relev
system
analyz
variou
concentr
multipl
subtyp
spike
whole
blood
phosphat
buffer
salin
pb
biolog
environ
virus
provid
sever
potenti
challeng
factor
includ
excess
level
albumin
casein
immunoglobulin
protein
might
caus
block
antigenantibodi
interact
nonspecif
bind
could
increas
nonspecif
background
signal
interfer
system
perform
henc
directli
detect
virus
biolog
sampl
crucial
test
evalu
biosens
perform
robust
system
evalu
multipl
hiv
subtyp
ie
b
c
e
g
panel
spike
whole
blood
fourier
type
curv
fit
analysi
describ
materi
method
section
spectral
measur
data
analysi
section
perform
record
spectra
ie
hiv
data
correspond
refer
curv
extract
wavelength
shift
hiv
subtyp
b
c
e
g
panel
spike
whole
blood
particular
blood
sampl
spike
copiesml
copiesml
copiesml
copiesml
copiesml
copiesml
copiesml
subtyp
b
c
e
g
panel
respect
sampl
result
wavelength
shift
nm
nm
nm
nm
nm
nm
nm
subtyp
b
c
e
g
panel
respect
figur
also
valid
hiv
viral
load
use
hivinfect
anonym
discard
patient
whole
blood
sampl
use
nanoplasmon
platform
presenc
discard
patient
sampl
highest
peak
shift
observ
nm
copiesml
figur
peak
shift
copiesml
hiv
viral
load
nm
figur
addit
whole
blood
test
evalu
hiv
subtyp
panel
suspens
pb
figur
use
two
data
analysi
approach
evalu
wavelength
shift
data
use
curv
fit
ii
experiment
data
maximum
method
describ
materi
method
spectral
measur
data
analysi
curv
fit
analysi
result
present
figur
experiment
data
maximum
method
result
present
figur
two
method
gave
compar
result
lower
viru
concentr
result
small
wavelength
shift
full
spectra
taken
account
curv
fit
method
evalu
small
shift
observ
curv
fit
method
better
suit
analysi
smaller
wavelength
shift
analyz
total
curv
antibodi
refer
curv
correspond
hiv
spike
whole
blood
sampl
peak
subtract
refer
obtain
shift
well
refer
measur
standard
error
mean
sem
away
mean
sampl
introduc
test
also
measur
well
gave
neg
shift
result
indic
well
variat
prepar
step
thu
includ
analysi
four
well
gave
neg
result
nm
hivspik
whole
blood
extinct
peak
subtract
antibodi
refer
well
includ
analysi
sinc
result
inconclus
potenti
due
variat
surfac
chemistri
addit
one
well
among
copiesml
copiesml
well
exclud
sinc
gave
shift
larger
subtyp
highest
concentr
plu
sem
addit
observ
shift
rang
nm
instrument
step
size
nm
valu
equival
noshift
noshift
may
due
fact
virus
captur
activ
area
data
point
includ
analysi
reflect
statist
natur
captur
event
earlier
outlin
captur
effici
calcul
support
inform
theoret
model
captur
effici
evalu
repeat
biosens
platform
technolog
defin
equat
present
support
inform
repeat
biosens
platform
repeat
paramet
describ
percent
variat
wavelength
shift
measur
viru
concentr
paramet
evalu
hiv
subtyp
present
vari
spike
sampl
concentr
figur
overal
repeat
paramet
observ
broad
rang
concentr
multipl
hiv
subtyp
result
indic
nanoplasmon
biosens
platform
reliabl
accur
repeat
feasibl
figur
result
also
demonstr
system
perform
show
compar
repeat
valu
multipl
hiv
subtyp
whole
blood
figur
addit
wavelength
shift
nanoplasmon
system
measur
extinct
intens
variat
caus
hiv
captur
event
captur
event
caus
wavelength
shift
extinct
intens
variat
result
acquir
wavelength
shift
extinct
intens
variat
evalu
extinct
intens
variat
figur
set
experi
wavelength
shift
plot
figur
nanoplasmon
platform
measur
signal
shift
caus
virus
captur
gold
nanoparticl
coat
surfac
concentr
virus
quantifi
rtqpcr
bulk
detect
techniqu
overal
wavelength
shift
result
captur
virus
calcul
present
plot
gener
standard
curv
perform
least
squar
fit
combin
data
hiv
subtyp
spike
whole
blood
bulk
hiv
concentr
quantifi
translat
shift
use
standard
curv
translat
surfac
detect
bulk
detect
figur
work
focus
global
shift
quantifi
bulk
concentr
obtain
rtqpcr
evalu
quantit
detect
first
obtain
standard
curv
hiv
spike
whole
blood
sampl
use
wavelength
shift
analyz
curv
fit
method
hiv
viral
load
obtain
rtqpcr
standard
curv
obtain
present
quantit
detect
result
use
biosens
platform
hivinfect
patient
sampl
figur
tabl
nanoplasmon
platform
present
viral
load
rang
log
copiesml
log
copiesml
patient
sampl
rtqpcr
count
present
viral
load
rang
log
copiesml
log
copiesml
patient
sampl
result
present
tabl
evalu
use
blandaltman
analysi
present
figur
blandaltman
analysi
nanoplasmon
platform
rtqpcr
show
evid
systemat
bia
hiv
viral
load
hivinfect
patient
blood
sampl
addit
analyz
extinct
intens
measur
patient
data
use
curv
fit
approach
present
result
figur
nanoplasmon
platform
present
viral
load
rang
log
copiesml
log
copiesml
patient
sampl
rtqpcr
count
present
viral
load
rang
log
copiesml
log
copiesml
patient
sampl
result
also
evalu
use
blandaltman
analysi
figur
analysi
show
evid
systemat
bia
hiv
viral
load
hivinfect
patient
blood
sampl
clinic
perspect
limit
detect
cover
rang
valu
includ
current
world
health
organ
definit
treatment
failur
viral
load
vl
copiesml
well
depart
health
human
servic
dhh
aid
clinic
trial
group
actg
definit
treatment
failur
vl
copiesml
estim
annual
infant
infect
mothertochild
transmiss
mtct
reduc
morbid
improv
qualiti
life
person
live
hivaid
rapidli
expand
access
antiretrovir
therapi
art
develop
countri
account
infect
howev
expans
significantli
restrict
lack
costeffect
poc
viral
load
assay
effect
reach
patient
live
rural
set
develop
countri
viral
load
regularli
use
close
monitor
assess
patient
respons
art
ensur
drug
adher
stage
diseas
progress
contrast
develop
countri
lymphocyt
count
clinic
symptom
use
guid
art
follow
guidelin
except
infant
viral
load
assay
requir
although
test
great
tool
monitor
patient
recent
studi
shown
cell
count
strategi
detect
earli
virolog
failur
howev
viral
load
assay
expens
per
test
instrumentdepend
technic
complex
develop
countri
one
import
issu
prevent
mtct
extend
aid
care
posit
infant
mtct
remain
primari
caus
aid
children
approxim
children
infect
per
day
rapid
progress
aid
infant
caus
earli
death
combin
data
nine
clinic
trial
africa
show
posit
infant
die
age
children
die
age
highlight
import
viral
load
monitor
prevent
mtct
resourceconstrain
set
studi
shown
longterm
suppress
replic
infant
achiev
initi
art
reduc
aidsrel
morbid
mortal
improv
qualiti
life
provid
earli
aid
care
art
hivinfect
infant
earli
diagnosi
key
howev
simpl
rapid
serolog
assay
detect
hivinfect
infant
month
birth
late
identif
aid
children
due
interfer
matern
specif
antibodi
passiv
transfer
placenta
persist
infant
approxim
month
thu
readili
avail
poc
viral
load
test
earli
detect
hivinfect
infant
urgent
need
resourceconstrain
set
one
potenti
applic
platform
technolog
infant
test
hiv
statu
monitor
white
blood
cell
count
nucleic
acid
amplif
assay
requir
anoth
potenti
applic
monitor
coinfect
tuberculosishiv
aid
epidem
region
present
nanoplasmon
platform
technolog
detect
virus
whole
blood
hivinfect
patient
contain
hiv
antibodi
sinc
antibodi
men
women
would
differ
antibodi
transfer
women
infant
would
expect
greater
effect
interf
detect
ie
antibodi
interfer
detect
infect
adult
passiv
transfer
antibodi
interfer
detect
infant
clinic
sampl
test
far
observ
interfer
effect
addit
virus
complet
neutral
antibodi
still
expos
antigen
viru
surfac
allow
captur
biosens
platform
detect
system
multipl
advantag
current
viral
load
test
eg
rtqpcr
assay
infant
adult
test
sinc
potenti
enabl
poc
test
significantli
increas
access
viral
load
monitor
resourceconstrain
set
reduc
cost
reagent
instrument
ii
reduc
complex
sampl
prepar
amplif
step
health
worker
perform
test
minim
train
iii
shorten
assay
time
hour
captureincub
minut
detect
data
analysi
oppos
hour
requir
rtqpcr
eg
coba
ampliprepcoba
taqman
test
decreas
captureincub
assay
time
nanoplasmon
platform
potenti
integr
microfluid
technolog
earlier
describ
addit
nanoplasmon
detect
system
detect
multipl
subtyp
use
polyclon
antibodi
target
multipl
epitop
enabl
captur
variou
hiv
subtyp
previous
report
polyclon
antibodi
use
gener
captur
agent
multipl
hiv
subtyp
despit
fact
differ
hiv
subtyp
mutat
variat
rna
genom
surfac
receptor
sever
discontinu
conserv
epitop
loop
surfac
protein
help
hiv
enter
lymphocyt
conserv
surfac
protein
allow
captur
variou
hiv
subtyp
use
singl
antibodi
therefor
use
platform
technolog
hiv
subtyp
could
also
captur
detect
quantifi
compar
effici
specif
due
conserv
epitop
report
test
hiv
subtyp
avail
us
nation
institut
health
nih
aid
research
refer
reagent
program
includ
panel
subtyp
contrast
rapid
evolut
mutat
caus
detect
challeng
rna
virus
eg
hiv
genet
divers
viru
subtyp
interfer
abil
pcr
test
recogn
current
subtyp
nanoplasmon
biosens
platform
signific
potenti
clinic
applic
surfac
chemistri
highli
specif
antibodi
immobil
util
minim
background
signal
sinc
background
signal
nois
potenti
gener
nonspecif
bind
blood
cell
pose
detect
challeng
low
concentr
especi
hivinfect
clinic
sampl
biosens
technolog
potenti
suffici
use
broadli
clinic
microbiolog
infecti
diseas
laboratori
moreov
platform
potenti
provid
reliabl
accur
inexpens
timeeffect
easetous
detect
system
global
scale
lifethreaten
infecti
diseas
includ
hiv
poxviru
herpesviru
virus
eg
sar
differ
detect
method
instanc
research
use
nasal
swab
bronchoalveolar
lavag
nasopharyng
aspir
exhal
breath
addit
blood
sampl
detect
method
studi
focus
bloodborn
diseas
ie
hiv
differ
type
human
sampl
differ
physiolog
condit
detect
platform
need
adapt
handl
differ
sampl
type
hand
present
technolog
versatil
platform
modifi
detect
pathogen
alter
surfac
chemistri
pathogen
reason
welldescrib
marker
avail
limit
detect
present
platform
demonstr
low
viral
concentr
whole
blood
copiesml
detect
nanoplasmon
detect
technolog
enabl
biosens
platform
multiplex
format
would
vital
role
biosensor
design
engin
select
specif
detect
multipl
pathogen
subtypesstrain
patient
sampl
use
immobil
highli
specif
antibodi
differ
region
sensor
area
present
nanoplasmon
technolog
provid
detect
platform
allow
fast
reliabl
sensit
specif
accur
label
fluorescencefre
quantif
assay
virus
whole
blood
without
sampl
prepar
demonstr
extraordinari
nanoplasmon
properti
nanoparticl
deploy
multipl
pathogen
subtyp
detect
platform
technolog
util
immobil
highli
specif
antivir
antibodi
biosens
surfac
select
specif
captur
detect
intact
virus
unprocess
clinic
sampl
give
viral
load
cover
broad
rang
clinic
relev
concentr
show
direct
captur
detect
quantif
platform
technolog
multipl
hiv
subtyp
b
c
e
g
panel
discard
patient
sampl
whole
blood
high
sensit
specif
addit
detect
virus
unprocess
whole
blood
demonstr
platform
technolog
feasibl
diagnosi
virus
directli
patient
sampl
nanoplasmon
detect
platform
detect
quantifi
intact
virus
without
damag
viru
structur
characterist
includ
capsid
structur
henc
platform
technolog
enabl
rapidli
isol
captur
detect
quantifi
intact
virus
biosens
platform
potenti
use
direct
multipl
pathogen
detect
use
nanoplasmon
properti
nanoparticl
take
signific
step
toward
provid
poc
test
resourceconstrain
set
well
hospit
primari
care
set
briefli
surfac
chemistri
perform
order
coat
polystyren
well
pll
hydrobromid
molecular
weight
sigma
co
st
loui
mo
ii
gold
nanoparticl
incub
pllcoat
surfac
iii
surfac
activ
coupl
reaction
mua
edcnh
aldrich
chemic
co
milwauke
wi
iv
coval
bind
neutravidin
pierc
biotechnolog
rockford
il
use
succinimid
ring
activ
surfac
v
block
nonspecif
bind
bsa
aldrich
chemic
co
milwauke
wi
vi
biotinyl
polyclon
antibodi
abcam
inc
cambridg
immobil
vii
applic
hiv
spike
sampl
whole
blood
pb
pipet
follow
surfac
modif
surfac
wash
pb
three
time
pipet
introduc
viru
sampl
nanoplasmon
platform
also
rins
pb
three
time
remov
unbound
virus
virus
captur
insid
detect
light
beam
area
spectromet
contribut
nanoplasmon
wavelength
extinct
intens
chang
data
subtract
spectra
measur
sampl
antibodi
immobil
result
shift
present
wavelength
extinct
intens
chang
standard
error
mean
sem
prepar
biosens
substrat
polystyren
surfac
mm
first
modifi
pll
gener
aminetermin
group
gold
nanoparticl
bind
pll
modif
gold
nanoparticl
solut
tedpella
red
ca
load
onto
surfac
incub
coeffici
variat
nanoparticl
indic
less
standard
deviat
size
variat
indic
nm
manufactur
gold
nanoparticl
immobil
mua
nethyln
carbodiimid
hydrochloridenhydroxysulfosuccinimid
edcnh
coupl
neutravidin
bind
biotinyl
polyclon
antibodi
immobil
util
surfac
minim
nonspecif
bind
inact
reactiv
area
surfac
bsa
use
block
agent
surfac
incub
hour
hiv
cultur
step
briefli
explain
support
inform
hiv
cultur
section
spike
hiv
whole
blood
hiv
subtyp
first
quantifi
revers
transcriptionquantit
polymeras
chain
reaction
rtqpcr
studi
use
commerci
rna
assay
coba
ampliprepcoba
taqman
test
perform
staff
brigham
women
hospit
quantifi
stock
concentr
differ
hiv
subtyp
sampl
cycl
threshold
ct
valu
greater
lowest
standard
point
copiesml
ct
valu
pcr
cycl
run
total
report
copiesml
low
copi
hiv
viral
load
earlier
report
use
revers
transcriptionquantit
polymeras
chain
reaction
rtqpcr
system
amplif
profil
neg
control
remain
threshold
cycl
amplif
sampl
includ
lowest
standard
display
ct
valu
less
ct
valu
hiv
sampl
incub
biosens
platform
hour
whole
blood
sampl
without
hiv
use
control
also
evalu
nanoplasmon
platform
discard
anonym
hivinfect
patient
whole
blood
sampl
sampl
obtain
massachusett
gener
hospit
boston
institut
review
board
approv
hiv
sampl
experi
perform
biosafeti
level
bsl
laboratori
biosens
platform
evalu
laboratori
hiv
sampl
fix
paraformaldehydecontain
solut
perform
replic
rtqpcr
measur
replic
nanoplasmon
measur
hiv
subtyp
patient
sampl
standard
error
rtqpcr
nanoplasmon
measur
report
minim
dilut
inaccuraci
second
set
rtqpcr
perform
three
time
dilut
hiv
spike
sampl
hiv
rna
quantif
protocol
use
discard
hiv
patient
sampl
support
inform
quantif
hiv
subtyp
rtqpcr
sampl
section
experi
perform
use
hiv
subtyp
b
c
e
g
panel
discard
anonym
hivinfect
patient
sampl
bind
studi
character
detect
shift
maximum
extinct
point
gold
nanoparticl
varioskan
flash
spectral
scan
multimod
reader
thermo
scientif
detect
light
beam
area
spectromet
indic
mm
maximum
spectral
resolut
intens
accuraci
instrument
fix
slit
set
nm
au
extinct
intens
measur
mode
set
scan
extinct
chang
per
wavelength
nm
nm
step
analyz
wavelength
data
employ
two
approach
ie
curv
fit
experiment
data
maximum
first
method
matlab
code
written
find
nanoplasmon
wavelength
peak
record
spectra
curv
fit
fourier
type
expans
harmon
ie
fundament
frequenc
signal
n
b
n
expans
coeffici
use
fit
record
spectra
r
valu
found
greater
matlab
fit
command
wavelength
maximum
extinct
valu
record
spectra
extract
curv
fit
round
first
decim
digit
consid
finit
resolut
experi
individu
refer
curv
subtract
perform
hiv
subtyp
curv
given
viru
concentr
correspond
refer
curv
data
wavelength
measur
present
mean
wavelength
measur
sem
experiment
spectra
evalu
experiment
data
maximum
method
compar
fourier
type
second
data
analysi
method
nanoplasmon
wavelength
peak
determin
wavelength
maximum
extinct
valu
data
wavelength
extinct
intens
measur
present
mean
wavelength
extinct
intens
measur
sem
hiv
subtyp
curv
given
viru
concentr
individu
refer
curv
subtract
carri
correspond
refer
curv
consid
resolut
instrument
data
present
one
decim
digit
result
error
finit
resolut
spectromet
consid
analysi
evalu
modif
gold
nanoparticl
analyz
experiment
result
use
nonparametr
kruskalw
oneway
analysi
varianc
follow
mannwhitney
u
test
bonferroni
correct
multipl
comparison
statist
signific
threshold
set
p
error
bar
repres
standard
error
mean
evalu
repeat
nanoplasmon
platform
count
use
residu
analysi
comparison
rtqpcr
count
blandaltman
comparison
analysi
use
coeffici
repeat
calcul
time
standard
deviat
differ
nanoplasmon
platform
rtqpcr
count
sampl
clinic
accept
rang
consid
interv
within
differ
measur
method
would
fall
confid
interv
statist
analys
perform
use
minitab
releas
minitab
inc
state
colleg
pa
refer
web
version
pubm
central
supplementari
materi
nanoplasmon
viral
load
detect
platform
hiv
captur
antibodi
immobil
biosens
surfac
b
captur
hiv
biosens
surfac
polystyren
surfac
first
modifi
polyllysin
pll
gener
amin
group
gold
nanoparticl
aunp
immobil
amin
termin
surfac
layerbylay
modif
perform
acid
mua
nethyln
carbodiimid
hydrochlorid
edc
nhydroxysulfosuccinimid
nh
coupl
neutravidin
biotinyl
polyclon
antibodi
prevent
nonspecif
bind
bovin
serum
albumin
bsa
use
block
agent
surfac
modif
hiv
captur
step
spectral
analysi
monitor
peak
shift
maximum
extinct
wavelength
record
surfac
character
polystyren
ps
substrat
surfac
modif
step
use
atom
forc
microscopi
afm
five
random
surfac
area
sampl
group
evalu
ps
substrat
without
surfac
modif
shown
b
ps
substrat
mgml
pll
treatment
present
c
gold
nanoparticl
aunp
immobil
polyllysin
pll
treat
surfac
aunp
immobil
nanoparticl
observ
surfac
root
mean
squar
rm
rough
surfac
evalu
signific
differ
observ
aunp
immobil
onto
surfac
compar
ps
substrat
without
pll
p
e
scan
electron
microscop
imag
captur
intact
virus
valid
hiv
spike
whole
blood
hivinfect
patient
sampl
use
experiment
data
curv
fit
method
fourier
type
curv
fit
analysi
perform
record
spectra
extract
extinct
peak
hiv
subtyp
spike
whole
blood
panel
sampl
error
bar
repres
standard
error
mean
result
correl
well
experiment
data
maximum
method
present
figur
viral
load
valu
obtain
rtqpcr
repeat
least
time
sampl
concentr
hiv
subtyp
whole
blood
led
nm
wavelength
shift
copiesml
b
copiesml
hiv
subtyp
b
spike
whole
blood
sampl
led
wavelength
shift
nm
c
sampl
hiv
subtyp
c
whole
blood
copiesml
concentr
evalu
peak
shift
observ
nm
copiesml
hiv
subtyp
whole
blood
sampl
result
wavelength
shift
nm
e
hiv
subtyp
e
whole
blood
evalu
observ
nm
wavelength
shift
copiesml
f
sampl
hiv
subtyp
g
whole
blood
copiesml
concentr
evalu
peak
shift
observ
nm
g
hiv
subtyp
panel
whole
blood
evalu
observ
nm
wavelength
shift
copiesml
h
discard
hiv
patient
sampl
whole
blood
evalu
observ
nm
wavelength
shift
copiesml
peak
shift
decreas
nm
lowest
concentr
copiesml
sampl
evalu
repeat
paramet
evalu
wavelength
shift
multipl
hiv
subtyp
variou
concentr
overal
repeat
paramet
observ
broad
rang
concentr
multipl
hiv
spike
discard
hiv
patient
sampl
data
wavelength
measur
present
wavelength
measur
standard
error
mean
sem
error
bar
repres
sem
viral
load
valu
obtain
rtqpcr
repeat
least
time
sampl
concentr
quantit
detect
hivinfect
patient
sampl
use
curv
fit
analysi
method
discard
hivinfect
patient
sampl
whole
blood
evalu
use
nanoplasmon
platform
correl
present
hiv
count
obtain
rtqpcr
nanoplasmon
platform
nanoplasmon
platform
present
viral
load
rang
log
copiesml
log
copiesml
patient
sampl
rtqpcr
count
present
viral
load
rang
log
copiesml
log
copiesml
patient
sampl
data
wavelength
measur
present
wavelength
measur
standard
error
mean
sem
error
bar
repres
sem
b
blandaltman
analysi
nanoplasmon
platform
rtqpcr
count
display
evid
systemat
bia
hiv
viral
load
hivinfect
patient
blood
sampl
test
quantit
measur
hivinfect
patient
sampl
use
method
present
tabl
